Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI116934

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

M Levi, H ten Cate, K A Bauer, T van der Poll, T S Edgington, H R Büller, S J van Deventer, C E Hack, J W ten Cate, and R D Rosenberg

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by Levi, M. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by ten Cate, H. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by Bauer, K. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by van der Poll, T. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by Edgington, T. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by Büller, H. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by van Deventer, S. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by Hack, C. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by ten Cate, J. in: PubMed | Google Scholar

Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center F4-237, Amsterdam, The Netherlands.

Find articles by Rosenberg, R. in: PubMed | Google Scholar

Published January 1, 1994 - More info

Published in Volume 93, Issue 1 on January 1, 1994
J Clin Invest. 1994;93(1):114–120. https://doi.org/10.1172/JCI116934.
© 1994 The American Society for Clinical Investigation
Published January 1, 1994 - Version history
View PDF
Abstract

Knowledge of the pathogenetic mechanisms responsible for the activation of the coagulation system associated with endotoxemia is important for the development of improved modalities for prevention and treatment. We analyzed the appearance in plasma of TNF, IL-6, and indices of coagulation and fibrinolytic system activation in normal chimpanzees after intravenous infusion of endotoxin. Endotoxin infusion elicited reproducible and dose-dependent elevations in serum TNF and IL-6, as well as marked increases in thrombin generation in vivo as measured by immunoassays for prothrombin activation fragment F1 + 2, thrombin-antithrombin III complexes, and fibrinopeptide A. Activation of the fibrinolytic mechanism was monitored with assays for plasminogen activator activity and plasmin-alpha 2-antiplasmin complexes. To potentially intervene in the molecular pathways elicited by endotoxin, pentoxifylline, an agent that interrupts "immediate early" gene activation by monocytes, or a potent monoclonal antibody that neutralizes tissue factor-mediated initiation of coagulation, were infused shortly before endotoxin. Pentoxifylline markedly inhibited increases in the levels of TNF and IL-6, as well as the effects on coagulation and fibrinolysis. In contrast, the monoclonal antibody to tissue factor completely abrogated the augmentation in thrombin generation, but had no effect on cytokine levels or fibrinolysis. We conclude that the endotoxin-induced activation of coagulation appears to be mediated by the tissue factor-dependent pathway, the fibrinolytic response triggered by endotoxin is not dependent on the generation of thrombin, and that the release of cytokines may be important in mediating the activation of both the coagulation and the fibrinolytic mechanisms in vivo.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 114
page 114
icon of scanned page 115
page 115
icon of scanned page 116
page 116
icon of scanned page 117
page 117
icon of scanned page 118
page 118
icon of scanned page 119
page 119
icon of scanned page 120
page 120
Version history
  • Version 1 (January 1, 1994): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts